A synthetic peptide of human apoprotein E with antibacterial activity

Peptides. 2000 Mar;21(3):327-30. doi: 10.1016/s0196-9781(00)00165-0.

Abstract

In recent years, several endogenous mammalian antibacterial peptides have been described. An amphipathic cationicalpha-helix is a common feature in many cases; therefore, other peptides with this characteristic might also possess antibiotic activity. In fact, a 30-mer peptide of apoprotein E 133-162 (LRVRLASHLRKLRKRLLRDADDLQKRLAVY) was found to have antibiotic activity comparable to those of a classic antibiotic (Gentamicin) and a neutrophil-derived antibiotic peptide (CAP18). Calculation of cationicity, hydrophobicity, and hydrophobic moment and the helical wheel diagram of apoprotein E 133-162 revealed close similarities to CAP18.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides*
  • Apolipoproteins E / chemistry*
  • Apolipoproteins E / pharmacology*
  • Bacteria / drug effects*
  • Carrier Proteins / pharmacology
  • Cathelicidins
  • Drug Resistance, Multiple
  • Escherichia coli / drug effects
  • Gentamicins / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Protein Structure, Secondary
  • Pseudomonas aeruginosa / drug effects
  • Salmonella / drug effects
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Apolipoproteins E
  • Carrier Proteins
  • Cathelicidins
  • Gentamicins
  • Peptide Fragments